Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertension

Détails

ID Serval
serval:BIB_A3982AAD1BCD
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertension
Périodique
Blood Pressure Monitoring
Auteur⸱e⸱s
Burnier  M.
ISSN
1359-5237 (Print)
Statut éditorial
Publié
Date de publication
2000
Volume
5 Suppl 1
Pages
S31-4
Notes
Journal Article
Review
Résumé
Despite improvements in the management of hypertension in the past several years and the numerous efficacious antihypertensive agents available to today's physician, nearly 70% of patients do not have their hypertension adequately controlled. Noncompliance with prescribed regimens appears to be one of the primary contributors to the large numbers of patients with uncontrolled hypertension. A behaviour that can affect all patients, noncompliance is perplexing because it remains largely unrecognized in clinical practice. Several types of noncompliance exist, the 'drug holiday' being the most common. Good communication with the patient and the entire health care team is essential to improving patient compliance. Long-acting medications that provide good control of blood pressure beyond the 24 h dosing period should be considered as the drugs of choice in noncompliant hypertensive patients. This article discusses different types of compliance, methods of measuring compliance, and the clinical consequences of noncompliance in hypertension.
Mots-clé
Antihypertensive Agents/administration & dosage Chronotherapy Drug Monitoring Humans Hypertension/psychology/*therapy *Patient Compliance/psychology Time Factors Treatment Refusal/psychology
Pubmed
Web of science
Création de la notice
25/01/2008 13:56
Dernière modification de la notice
20/08/2019 16:09
Données d'usage